Serum atrial natriuretic peptide levels among clomiphene citrate resistant polycystic ovarian syndrome patients
| Autor: | Alaa Wageh, Noha Eladawi, Mohamed Sayed Abdelhafez, Mona Abo Bakr El-Hussiny, Ahmed Gibreel, Maha E. Houssen, Ola Ali El-Emam |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
endocrine system diseases lcsh:QH471-489 medicine.medical_treatment 03 medical and health sciences 0302 clinical medicine Insulin resistance Atrial natriuretic peptide Internal medicine medicine lcsh:Reproduction 030212 general & internal medicine lcsh:R5-920 030219 obstetrics & reproductive medicine business.industry Insulin Obstetrics and Gynecology Insulin sensitivity nutritional and metabolic diseases medicine.disease Endocrinology Reproductive Medicine business lcsh:Medicine (General) METABOLIC FEATURES Homeostasis hormones hormone substitutes and hormone antagonists |
| Zdroj: | Middle East Fertility Society Journal, Vol 23, Iss 4, Pp 370-372 (2018) |
| ISSN: | 1110-5690 |
| Popis: | Aim: To investigate whether atrial natriuretic peptide (ANP) level is altered in polycystic ovarian syndrome (PCOS) patients with clomiphene citrate (CC) resistant and whether it correlates with insulin sensitivity markers. Methods: Serum ANP, insulin and glucose levels and the homeostasis model assessment for insulin resistance index (HOMA-IR) were evaluated among a group of PCOS women with CC resistance (n = 40). A control group (n = 30) was selected from healthy women with regular menstrual cycles. Results: Serum ANP level was significantly lower in the study group than in the control group (0.74 ± 1.1 ng/ml vs 3.17 ± 1.9 ng/ml; P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|